A prospective study of risk factors for in-hospital mortality in patients with malignant obstructive jaundice undergoing percutaneous biliary drainage
- PMID: 30985679
- PMCID: PMC6485810
- DOI: 10.1097/MD.0000000000015131
A prospective study of risk factors for in-hospital mortality in patients with malignant obstructive jaundice undergoing percutaneous biliary drainage
Abstract
Background: The in-hospital mortality rate in patients undergoing percutaneous transhepatic biliary drainage (PTBD) for malignant obstructive jaundice (MOJ) is high. There are few reports on the risk factors associated with hospital death after MOJ, with most of them being retrospective analyses of single factors. Therefore, this study aimed to assess pre-, intra-, and post-procedure risk factors that were independently associated with increased in-hospital mortality in MOJ patients who underwent PTBD.
Methods: One-hundred fifty-five patients with MOJ who underwent initial PTBD were included in this study. A total of 25 pre-, 4 intra-, and 6 post-procedure factors potentially related to in-hospital mortality were assessed by univariate and multivariate analyses.
Results: The in-hospital mortality rate was 16.8% (26/155). Of 25 pre-procedure variables analyzed, Child-Pugh classification C, creatinine level ≥6.93 μmol/L, and quality-of-life score (≤30) were found to be significant in univariate and multivariate analyses. Increased mortality was observed in patients with 2 or more risk factors, which was significantly different from patients with no risk factors or one risk factor (P < .01). None of the intra-procedure factors were important in identifying patients at risk of death. Multivariate analysis indicated post-PTBD cholangitis and unsuccessful drainage as post-procedure risk factors that correlated with in-hospital death.
Conclusion: It was identified that in-hospital mortality was associated with 3 pre-procedure and 2 post-procedure risk factors, such as the liver function classification, quality-of-life score of cancer patients, creatinine level, PTBD-associated biliary duct infection, and unsuccessful drainage.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Similar articles
-
Ten years single center experience in percutaneous transhepatic decompression of biliary tree in patients with malignant obstructive jaundice.Adv Clin Exp Med. 2012 Sep-Oct;21(5):621-32. Adv Clin Exp Med. 2012. PMID: 23356199
-
Outcomes of percutaneous transhepatic gallbladder drainage versus percutaneous transhepatic biliary drainage for obstructive jaundice.PLoS One. 2025 Feb 24;20(2):e0310469. doi: 10.1371/journal.pone.0310469. eCollection 2025. PLoS One. 2025. PMID: 39993017 Free PMC article.
-
The outcomes of biliary drainage by percutaneous transhepatic cholangiography for the palliation of malignant biliary obstruction in England between 2001 and 2014: a retrospective cohort study.BMJ Open. 2020 Jan 23;10(1):e033576. doi: 10.1136/bmjopen-2019-033576. BMJ Open. 2020. PMID: 31980509 Free PMC article.
-
How to Choose Between Percutaneous Transhepatic and Endoscopic Biliary Drainage in Malignant Obstructive Jaundice: An Updated Systematic Review and Meta-analysis.In Vivo. 2020 Jul-Aug;34(4):1701-1714. doi: 10.21873/invivo.11964. In Vivo. 2020. PMID: 32606139 Free PMC article.
-
Hepatocellular carcinoma with obstructive jaundice: endoscopic and percutaneous biliary drainage.Dig Dis. 2012;30(6):592-7. doi: 10.1159/000343087. Epub 2012 Dec 13. Dig Dis. 2012. PMID: 23258100 Review.
Cited by
-
Clinical outcomes of percutaneous transhepatic biliary drainage at different Couinaud's hepatic entry segments for treating obstructive jaundice.Front Surg. 2023 Jan 24;10:1039106. doi: 10.3389/fsurg.2023.1039106. eCollection 2023. Front Surg. 2023. PMID: 36761028 Free PMC article.
-
Self-expandable metallic stent with 125I seed strand in malignant biliary obstruction: a self-made delivery system and novel implantation method.Ann Transl Med. 2021 Dec;9(24):1774. doi: 10.21037/atm-21-6392. Ann Transl Med. 2021. PMID: 35071468 Free PMC article.
-
Retrospective analysis of T-lymphocyte subsets and cytokines in malignant obstructive jaundice before and after external and internal biliary drainage.J Int Med Res. 2021 Feb;49(2):300060520970741. doi: 10.1177/0300060520970741. J Int Med Res. 2021. PMID: 33641475 Free PMC article.
-
An alternative palliative surgical method for advanced malignant obstructive jaundice: Laparoscopic bridge choledochoduodenostomy.Front Surg. 2023 Jan 6;9:1056093. doi: 10.3389/fsurg.2022.1056093. eCollection 2022. Front Surg. 2023. PMID: 36684379 Free PMC article.
-
Efficacy and safety of hepatic artery infusion chemotherapy with mFOLFOX in primary liver cancer patients with hyperbilirubinemia and ineffective drainage: a retrospective cohort study.Ann Transl Med. 2022 Apr;10(7):411. doi: 10.21037/atm-22-978. Ann Transl Med. 2022. PMID: 35530940 Free PMC article.
References
-
- van Delden OM, Lameris JS. Percutaneous drainage and stenting for palliation of malignant bile duct obstruction. Eur Radiol 2008;18:448–56. - PubMed
-
- Comparison of endoscopic ultrasonography guided biliary drainage and percutaneous transhepatic biliary drainage in the management of malignant obstructive jaundice after failed ERCP: Erratum. Surg Laparosc Endosc Percutan Tech 2018;28:133. - PubMed
-
- Inal M, Akgul E, Aksungur E, et al. Percutaneous self-expandable uncovered metallic stents in malignant biliary obstruction. Complications, follow-up and reintervention in 154 patients. Acta Radiol 2003;44:139–46. - PubMed
-
- Stoker J, Lameris JS, Jeekel J. Percutaneously placed Wallstent endoprosthesis in patients with malignant distal biliary obstruction. Br J Surg 1993;80:1185–7. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources